コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 7) with Actinobacillus pleuropneumoniae and Pasteurella multocida.
2 ia meningitidis, Haemophilus influenzae, and Pasteurella multocida.
3 ilus influenzae, Neisseria meningitidis, and Pasteurella multocida.
4 acteria including Haemophilus influenzae and Pasteurella multocida.
5 Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida.
6 5 from Haemophilus influenzae and Oma87 from Pasteurella multocida.
7 nia pestis and the human and animal pathogen Pasteurella multocida.
8 tion of the pig's upper respiratory tract by Pasteurella multocida.
9 ely related species, Actinobacillus suis and Pasteurella multocida.
10 gaard taxon 45, an unnamed close relative of Pasteurella multocida.
12 l pathogens, including Haemophilus parasuis, Pasteurella multocida, Actinobacillus pleuropneumoniae,
14 c nonfastidious species were as follows: for Pasteurella multocida and staphylococci tested on Muelle
15 ents were conducted with a zoonotic pathogen Pasteurella multocida and the fluoroquinolone enrofloxac
16 Synechocystis sp., Deinococcus radiodurans, Pasteurella multocida, and Actinobacillus actinomycetemc
18 isease is caused by Gram-negative bacterium, Pasteurella multocida, and is considered to be endemic i
20 zae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as pr
22 ecies for known seabird pathogens, including Pasteurella multocida (avian cholera) (9.9% [6.6-14.0] i
23 ly potent against the Gram-negative pathogen Pasteurella multocida both in vitro and in a mouse infec
24 eir potencies against the bacterial pathogen Pasteurella multocida both in vitro and in mouse infecti
28 oop sequences from Enterococcus faecalis and Pasteurella multocida gamma-GCS-GS, isoforms that are in
31 gmented genomic DNA from the animal pathogen Pasteurella multocida has identified a gene encoding a p
32 P]UDP products made by the purified class II Pasteurella multocida HAS were not released by adding un
37 the literature, of ocular infections due to Pasteurella multocida include: endophtalmitis, keratitis
45 e rapid, accurate method to detect toxigenic Pasteurella multocida is needed for improved clinical di
50 bacteria, including Haemophilus influenzae, Pasteurella multocida, Neisseria gonorrhoeae, Neisseria
51 se of rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculatio
52 enes encoding Haemophilus influenzae D15 and Pasteurella multocida Oma87 protective outer membrane an
55 an synthases from the Gram-negative bacteria Pasteurella multocida, PmHS1 and PmHS2, were efficiently
56 The intracellularly acting protein toxin of Pasteurella multocida (PMT) causes numerous effects in c
57 hase, PmCS, from the Gram-negative bacterium Pasteurella multocida polymerize the glycosaminoglycan (
59 isolates and 4 attenuated vaccine strains of Pasteurella multocida recovered from multiple avian spec
61 Neuraminidases produced by 16 strains of Pasteurella multocida (serotypes 1 to 16) were character
64 -ray crystal structures of a multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1) w
65 he structures of a truncated multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1),
66 ot multienzyme sialylation system containing Pasteurella multocida sialyltransferase 3 (PmST3) with i
68 ntical for P. multocida subsp. multocida and Pasteurella multocida subsp. gallicida but differs from
69 e more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocida and Pasteurella m
71 , Pasteurella multocida subsp. multocida and Pasteurella multocida subsp. septica are among the most
72 mediates adhesion of serogroup A strains of Pasteurella multocida to elicited turkey air sac macroph
73 as assessed by exposing broth suspensions of Pasteurella multocida to perflubron for various times.
74 agonists and phospholipase C is activated by Pasteurella multocida toxin (a G(q) alpha-subunit agonis
81 atalytic and receptor-binding domains of the Pasteurella multocida toxin (PMT) were investigated.
82 not obvious and is explored with recombinant Pasteurella multocida toxin (rPMT, a Galpha(q) agonist).
83 ion on its own, it potentiated the effect of Pasteurella multocida toxin by 2-fold and ionomycin by 3
85 quires protein kinase C and MEK activity) by Pasteurella multocida toxin, a Galpha(q) agonist that pr
86 er these conditions, treatment of cells with Pasteurella multocida toxin, a selective inhibitor of Ga
87 channel current inhibition was diminished by Pasteurella multocida toxin, mimicked by constitutively
91 des tryptophanase; as well as a homologue of Pasteurella multocida tsaA, which encodes an alkyl perox
92 in a single polypeptide as was found for the Pasteurella multocida Type A PmHAS, the hyaluronan synth
97 The extracellular polysaccharide capsules of Pasteurella multocida types A, D, and F are composed of
98 ue of the NeuA C-terminal domain (Pm1710) in Pasteurella multocida was also shown to be an esterase,
100 tive causative agent of Saiga mass die-offs, Pasteurella multocida, was not detected in the Saiga mic
101 ytica and three matched pairs of isolates of Pasteurella multocida were isolated by using a nasal swa
102 The major outer membrane protein (OmpH) of Pasteurella multocida X-73 was purified by selective ext